Search results for: 'btk inhibitor 1'
-
A4147 LY2784544Target: Aurora Kinases|FLT3|VEGFR|FGFR|Trk Receptors|JAK|ALK|TYK2|MUSK|MAP3KSummary: JAK2 inhibitor,highly potent and selective
-
A2597 Brivanib (BMS-540215)Target: VEGFR|FGFR|Flk1Summary: VEGFR-2 inhibitor,ATP-competitive
-
A8683 NVP-BHG712Target: Eph Receptors|VEGFRSummary: EphB4 inhibitor,potent and selective
-
A3022 Pazopanib (GW-786034)Target: CSF-1R|VEGFR|PDGFR|c-Kit|FGFRSummary: VEGFR/PDGFR/FGFR inhibitor
-
A4125 CYC116Target: Aurora Kinases|FLT3|VEGFRSummary: Potent Aurora A/B inhibitor
-
A8313 RAF265Target: Raf|VEGFRSummary: Multiple intracellular kinases inhibitor
-
A3750 Regorafenib hydrochlorideTarget: Raf|VEGFR|PDGFR|c-Kit|c-RETSummary: Tyrosine kinase inhibitor
-
B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR).